Document is current
Any future updates will be listed below
-
Authors
Hoekstra, P. T. http://orcid.org/0000-0002-7285-9223
Casacuberta Partal, M.
Amoah, A. S.
van Lieshout, L.
Corstjens, P. L. A. M.
Tsonaka, S.
Assaré, R. K.
Silué, K. D.
Meité, A.
N’Goran, E. K.
N’Gbesso, Y. K.
Roestenberg, M.
Knopp, S.
Utzinger, J.
Coulibaly, J. T.
van Dam, G. J.
-
Funding
Funding for this research was provided by:
Prof. Dr. P.C. Flu Foundation (award letter dated February 14th 2016)
The Task Force for Global Health (NTD-SC 087G)
- License Information
-
More Information
Article History
Received: 2 November 2018
Accepted: 23 November 2018
First Online: 14 December 2018
Ethics approval and consent to participate
: Ethical approval for this study has been obtained from the National Ethics Committee of the Ministry of Health in Côte d’Ivoire (CNESVS, registration number 091–18/MSHP/CNESVS-km, 27 June 2018) as well as from the Direction de la Pharmacie, du Médicament et des Laboratoires de Côte d’Ivoire (DPML, registration number 99433-/MSHP/DGS/DPML/DAR and clinical trial number ECCI00618, 22 October 2018).Oral and signed assent and signed informed consent will be obtained from their legally appointed representative, usually a parent or guardian, responsible for making decisions on their behalf, prior to study enrolment.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
